Correction: Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping

Seongjin Choi,Margaret Spini,Jun Hua,Daniel M. Harrison

DOI: https://doi.org/10.1371/journal.pone.0264452

IF: 3.7

2022-02-22

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0249973.].

multidisciplinary sciences

What problem does this paper attempt to address?

Correction: Sub-millimetre resolution laminar fMRI using Arterial Spin Labelling in humans at 7 T

The PLOS ONE Staff

DOI: https://doi.org/10.1371/journal.pone.0251774

IF: 3.7

2021-05-12

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0250504.].

multidisciplinary sciences
Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Xiongjie Fu,Hanhai Zeng,Jikuang Zhao,Guoyang Zhou,Hang Zhou,Jianfeng Zhuang,Chaoran Xu,Jianru Li,Yucong Peng,Yang Cao,Yin Li,Huaijun Chen,Lin Wang,Feng Yan,Gao Chen

DOI: https://doi.org/10.1007/s12975-021-00919-z

2021-01-01

Translational Stroke Research

Abstract:Correction to this paper has been published: https://doi.org/10.1007/s12975-021-00919-z
Correction to: Exploring Alzheimer's disease: a comprehensive brain connectome-based survey

DOI: https://doi.org/10.1093/psyrad/kkae019

2024-09-26

Psychoradiology

Abstract:[This corrects the article DOI: 10.1093/psyrad/kkad033.].
Corrigendum: Diagnosis for autism spectrum disorder children using T1-based gray matter and arterial spin labeling-based cerebral blood flow network metrics

Mingyang Liu,Weibo Yu,Dandan Xu,Miaoyan Wang,Bo Peng,Haoxiang Jiang,Yakang Dai

DOI: https://doi.org/10.3389/fnins.2024.1480497

2024-09-16

Abstract:[This corrects the article DOI: 10.3389/fnins.2024.1356241.].
Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice.

Neel R Nabar,Fang Yuan,Xiaoyang Lin,Li Wang,Ge Bai,Jonathan Mayl,Yaqiong Li,Shu-Feng Zhou,Jinhuan Wang,Jianfeng Cai,Chuanhai Cao

DOI: https://doi.org/10.1371/journal.pone.0303619

IF: 3.7

2024-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0049468.].
Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Ting Lei,Zhihang Yang,Xue Xia,Yuxiu Chen,Xiaotong Yang,Rou Xie,Fan Tong,Xiaolin Wang,Huile Gao

DOI: https://doi.org/10.1016/j.apsb.2022.04.008

IF: 14.903

2022-04-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.04.022.].

pharmacology & pharmacy
Correction: Revealing Topological Organization of Human Brain Functional Networks with Resting-State Functional Near Infrared Spectroscopy

Haijing Niu,Jinhui Wang,Tao Zhao,Ni Shu,Yong He

DOI: https://doi.org/10.1371/annotation/8941aee3-4bb8-42a0-b09a-e7c416beeef7

IF: 3.7

2013-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0045771.].
Correction To: Activation of Sigma-1 Receptor Enhanced Pericyte Survival Via the Interplay Between Apoptosis and Autophagy: Implications for Blood–Brain Barrier Integrity in Stroke

Zhang Yuan,Zhang Xiaotian,Wei Qiangqiang,Leng Shuo,Li Cai,Han Bing,Bai Ying,Zhang Huibin,Yao Honghong

DOI: https://doi.org/10.1007/s12975-019-00711-0

2020-01-01

Translational Stroke Research

Abstract:In the original publication of this article, the representative western blot images of β-actin in Fig. 3e was presented repeatedly in Fig. 7b due to the same set of samples isolated from tissue of WT and σ-1R KO treated with pMCAO.
Corrigendum: Impaired Glymphatic Transport Kinetics Following Induced Acute Ischemic Brain Edema in a Mouse Pmcao Model

Jianying Zhang,Hongchen Zhao,Xue Yang,Yiqi Liu,Guohang Fan,He Wang,Qiang Dong,Wenjie Cao

DOI: https://doi.org/10.3389/fneur.2022.929798

IF: 3.4

2022-01-01

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2022.860255.].
Corrigendum to “the Neuroprotective Effect of Deep Brain Stimulation at Nucleus Basalis of Meynert in Transgenic Mice with Alzheimer’s Disease” [brain Stimul 12 (2019) 161–174]

Chuyi Huang,Heling Chu,Yu Ma,Zaiying Zhou,Chuanfu Dai,Xiaowen Huang,Liang Fang,Qiang Ao,Dongya Huang

DOI: https://doi.org/10.1016/j.brs.2021.01.019

IF: 9.184

2021-01-01

Brain Stimulation

Abstract:The authors noticed that in Fig. 6, there are similarities between the two images: WT DBS group and APP/PS1 control group in Hoechst staining. This error was inadvertently made during image assembly. The error has now been corrected as shown below. This correction does not affect the results or conclusions of the work. We apologize for any inconvenience caused. The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's diseaseBrain Stimulation: Basic, Translational, and Clinical Research in NeuromodulationVol. 12Issue 1PreviewAlzheimer's disease (AD) is the most common type of dementia and mainly treated by drugs, while the therapeutic outcomes are very limited. This study aimed to determine the optimized parameters of deep brain stimulation (DBS) which was applied to the treatment of AD and propose the involved mechanisms. Full-Text PDF
Author Correction: Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Catherine J. Mummery,Anne Börjesson-Hanson,Daniel J. Blackburn,Everard G. B. Vijverberg,Peter Paul De Deyn,Simon Ducharme,Michael Jonsson,Anja Schneider,Juha O. Rinne,Albert C. Ludolph,Ralf Bodenschatz,Holly Kordasiewicz,Eric E. Swayze,Bethany Fitzsimmons,Laurence Mignon,Katrina M. Moore,Chris Yun,Tiffany Baumann,Dan Li,Daniel A. Norris,Rebecca Crean,Danielle L. Graham,Ellen Huang,Elena Ratti,C. Frank Bennett,Candice Junge,Roger M. Lane

DOI: https://doi.org/10.1038/s41591-023-02639-3

IF: 82.9

2023-10-17

Nature Medicine

Abstract:Nature Medicine - Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

biochemistry & molecular biology,cell biology,medicine, research & experimental
Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Yang Han,Chunhong Gao,Hao Wang,Jiejie Sun,Meng Liang,Ye Feng,Qianqian Liu,Shiyao Fu,Lin Cui,Chunsheng Gao,Yi Li,Yang Yang,Baoshan Sun

DOI: https://doi.org/10.1016/j.bioactmat.2021.06.002

IF: 18.9

2022-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2020.08.017.].

engineering, biomedical,materials science, biomaterials
Correction of T 1 Effects in Calculation of Relative Recirculation in Ischemic Stroke Patients

Lixia Yuan,Xinfeng Yu,Minming Zhang,Quan Jiang,Yiping P. Du

DOI: https://doi.org/10.1007/s40846-016-0167-3

IF: 2

2016-01-01

Journal of Medical and Biological Engineering

Abstract:Relative recirculation (rR) is a promising surrogate permeability biomarker derived from dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI), and can be applied to predict hemorrhagic transformation (HT). However, the influence of T 1 effects on the calculation of rR has not been properly investigated. Furthermore, a correction method for T 1 effects in rR calculation has not been reported. In this study, a two-compartment model is used to simulate the influence of T 1 effects on rR under various imaging conditions. The results of the simulation demonstrate that the rR values calculated with T 1 effects are smaller than, or even have the opposite sign, compared to those calculated without T 1 effects. Data of 17 DSC–MRI scans were obtained from 14 ischemic stroke patients known to have blood–brain barrier (BBB) disruption on post-contrast T 1 -weighted images. A method is proposed to correct the T 1 effects in the calculation of rR, and applied to analyze the ischemic stroke patient dataset. The statistics from an in vivo study show that the corrected rR in BBB disruption regions is significantly higher than the uncorrected rR ( p < 0.05). Specifically, the corrected rR is positive, whereas the uncorrected rR is negative. rR values calculated without removing T 1 effects can be severe underestimations. Using the proposed T 1 correction method, the obtained rR can be adjusted to a level in accordance with known vascular physiology. As a semi-quantitative biomarker, rR with a high accuracy can potentially improve clinical assessment, such as the prediction of HT.
Author Correction: Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer’s disease mouse model

Georgia R. Frost,Valerie Longo,Thomas Li,Lauren A. Jonas,Martin Judenhofer,Simon Cherry,Jason Koutcher,Carl Lekaye,Pat Zanzonico,Yue-Ming Li

DOI: https://doi.org/10.1038/s41598-020-70134-7

IF: 4.6

2020-08-11

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Correction to Organic Radical Contrast Agents for Magnetic Resonance Imaging

Andrzej Rajca,Ying Wang,Michael Boska,Joseph T. Paletta,Arnon Olankitwanit,Michael A. Swanson,Deborah G. Mitchell,Sandra S. Eaton,Gareth R. Eaton,Suchada Rajca

DOI: https://doi.org/10.1021/ja413028d

IF: 15

2014-01-01

Journal of the American Chemical Society

Abstract:We re-examined the T1 weighted raw data and found that the raw signal intensity scale was changing despite the designation of “absolute value” reconstruction on the Bruker scanner. There was a hidden “slope” factor that modifies the raw intensities when the absolute value reconstruction was designated. This does not affect the signal within a single acquisition, such as the T1 mapping data, but does affect the intensity scales before and after injection of contrast agent. Elimination of this scaling factor (done via user designation of the slope and offset in the reconstruction options) eliminates this factor and provides a true rendering of the signal changes with constant acquisition parameters and constant receiver gain (which was done in all experiments). Page 15726. Correction to the subtraction images and caption in Figure 3. We obtain corrected subtraction image
Erratum: Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013;121(16):3237-3245

DOI: https://doi.org/10.1182/blood-2016-04-713727

IF: 20.3

2016-06-16

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2012-10-464156.].
Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

Xiaoying Chen,Maria Firulyova,Melissa Manis,Jasmin Herz,Igor Smirnov,Ekaterina Aladyeva,Chanung Wang,Xin Bao,Mary Beth Finn,Hao Hu,Irina Shchukina,Min Woo Kim,Carla M. Yuede,Jonathan Kipnis,Maxim N. Artyomov,Jason D. Ulrich,David M. Holtzman

DOI: https://doi.org/10.1038/s41586-024-08200-7

IF: 64.8

2024-10-17

Nature

Abstract:Nature, Published online: 16 October 2024; doi:10.1038/s41586-024-08200-7 Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

multidisciplinary sciences
Corrigendum: Evaluation of Glymphatic System Using Diffusion MR Technique in T2DM Cases

Guangwei Yang,Nan Deng,Yi Liu,Yingjiang Gu,Xiang Yao

DOI: https://doi.org/10.3389/fnhum.2020.616400

IF: 3.473

2021-01-26

Frontiers in Human Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnhum.2020.00300.].

psychology,neurosciences
Erratum: Combining patient-lesion and big data approaches to reveal hippocampal contributions to spatial memory and navigation

Sara Pishdadian,Antoine Coutrot,Lauren Webber,Michael Hornberger,Hugo Spiers,R Shayna Rosenbaum

DOI: https://doi.org/10.1016/j.isci.2024.111441

IF: 5.8

2024-11-22

iScience

Abstract:[This corrects the article DOI: 10.1016/j.isci.2024.109977.].
Correction: Personalizing Deep Brain Stimulation Therapy for Parkinson's Disease With Whole-Brain MRI Radiomics and Machine Learning

Nikolaos Haliasos,Dimitrios Giakoumettis,Prathishta Gnanaratnasingham,Hu Liang Low,Anjum Misbahuddin,Panagiotis Zikos,Vangelis Sakkalis,Spanaki Cleo,Antonios Vakis,Sotirios Bisdas

DOI: https://doi.org/10.7759/cureus.c195

2024-09-30

Cureus

Abstract:[This corrects the article DOI: 10.7759/cureus.59915.].

Correction: Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping

Correction: Sub-millimetre resolution laminar fMRI using Arterial Spin Labelling in humans at 7 T

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Correction to: Exploring Alzheimer's disease: a comprehensive brain connectome-based survey

Corrigendum: Diagnosis for autism spectrum disorder children using T1-based gray matter and arterial spin labeling-based cerebral blood flow network metrics

Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice.

Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Correction: Revealing Topological Organization of Human Brain Functional Networks with Resting-State Functional Near Infrared Spectroscopy

Correction To: Activation of Sigma-1 Receptor Enhanced Pericyte Survival Via the Interplay Between Apoptosis and Autophagy: Implications for Blood–Brain Barrier Integrity in Stroke

Corrigendum: Impaired Glymphatic Transport Kinetics Following Induced Acute Ischemic Brain Edema in a Mouse Pmcao Model

Corrigendum to “the Neuroprotective Effect of Deep Brain Stimulation at Nucleus Basalis of Meynert in Transgenic Mice with Alzheimer’s Disease” [brain Stimul 12 (2019) 161–174]

Author Correction: Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Correction of T 1 Effects in Calculation of Relative Recirculation in Ischemic Stroke Patients

Author Correction: Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer’s disease mouse model

Correction to Organic Radical Contrast Agents for Magnetic Resonance Imaging

Erratum: Flanagan JM, Sheehan V, Linder H, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013;121(16):3237-3245

Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

Corrigendum: Evaluation of Glymphatic System Using Diffusion MR Technique in T2DM Cases

Erratum: Combining patient-lesion and big data approaches to reveal hippocampal contributions to spatial memory and navigation

Correction: Personalizing Deep Brain Stimulation Therapy for Parkinson's Disease With Whole-Brain MRI Radiomics and Machine Learning